Assessment of Efficacy and Safety of Ivermectin in the Patients of COVID-19
AbstractObjective: Primary objective of the study is to evaluate the efficacy and safety of ivermectin in reducing the progression and severity of Covid-19. Secondary objective of the study is to compare viral clearance rate among the study group and evaluation of side effects of therapy.
MethodsThis cross-sectional observational study was undertaken at Department of Pulmonology Fatima Memorial Hospital, Lahore.After taking a medical history and doing a physical examination, oral ivermectin(12 mg once daily for 5 days) was given to 350 patients with COVID-19. Throughout treatment, the clinical efficacy of ivermectin, viral clearance rate, and adverse effects of medication were assessed and recorded on a prepared Performa.
Results Ivermectin therapy demonstrated 99.9 percent efficacy in patients treated with it. The paired sample t test revealed statistically significant differences in radiographic findings and PCR laboratory examination prior to and following ivermectin administration. While all clinical symptoms improved following medication. On the other hand, 2 persons (4%) have reported experiencing adverse effects from the medicine.
Conclusion Ivermectin induction has been presented as a more successful technique for treating Covid-19 infection
Keywords:Ivermectin, Covid-19, anti-helmenthic
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments firstname.lastname@example.org